β-adrenoceptor modulation and heart rate variability - the value of scatterplot measures of compactness
β-adrenoceptor modulation and heart rate variability - the value of scatterplot measures of compactness
This article compares different methods of scatterplot analysis to assess the optimal methodology. The scatterplot (Poincaré plot) is a nonlinear heart rate variability method where a "return map" is constructed by plotting each current cycle against the previous beat (RR vs. RRn–1). Geometric analysis of the scatterplot allows short-term and long-term heart rate variability (HRV) to be assessed. A three-dimensional construct is also possible, where the third axis represents the density of values, at any given RR vs. RRn–1 intersection. Topological methods of analysis can compute the density distribution function or compactness of a dataset. Scatterplots that otherwise appear very similar in the two-dimensional plot may be clearly differentiated using this approach. Correct characterization may improve the ability of scatterplot analysis to predict outcomes in cardiovascular disease. We have assessed two computational approaches that take account of scatterplot density, namely, the heart rate variability fraction and the compactness measure. Scatterplots were constructed from three double-blind and randomized placebo controlled studies conducted in a total of 49 healthy subjects. Single oral doses of antagonists (atenolol 50 mg [beta-1, propranolol 160 mg [beta-1 and beta-2], and ICI 118,551 25 mg [beta-2]) or agonists (xamoterol 200 mg [beta-1], salbutamol 8 mg [beta-2], prenalterol 50 mg [beta-1 and beta-2], and pindolol 10 mg [mainly beta-2] of the cardiac beta-adrenoceptor were studied. Salbutamol, pindolol, and xamoterol increased compactness and reduced HRV fraction significantly compared with placebo. However, when compared with the more conventional scatterplot parameters, these newer density methods were found to be less discriminating. An alternative approach to improve scatterplot discrimination, using the combination of several scatterplot features, is under investigation.
heart rate variability, scatterplot, compactness, beta-adrenoceptor, agonist antagonist
433-440
Silke, B.
299be5ab-bb02-46e0-8cf4-ed2fc26e61fb
Manratty, G.G.
3ef2e293-cb55-4538-a092-55bd304784b9
Veres, S.M.
909c60a0-56a3-4eb6-83e4-d52742ecd304
Riddell, J.G.
ebde366b-5d78-40e6-a7b0-da361f566073
2000
Silke, B.
299be5ab-bb02-46e0-8cf4-ed2fc26e61fb
Manratty, G.G.
3ef2e293-cb55-4538-a092-55bd304784b9
Veres, S.M.
909c60a0-56a3-4eb6-83e4-d52742ecd304
Riddell, J.G.
ebde366b-5d78-40e6-a7b0-da361f566073
Silke, B., Manratty, G.G., Veres, S.M. and Riddell, J.G.
(2000)
β-adrenoceptor modulation and heart rate variability - the value of scatterplot measures of compactness.
Cardiovascular Drugs and Therapy, 14 (4), .
(doi:10.1023/A:1007872418215).
Abstract
This article compares different methods of scatterplot analysis to assess the optimal methodology. The scatterplot (Poincaré plot) is a nonlinear heart rate variability method where a "return map" is constructed by plotting each current cycle against the previous beat (RR vs. RRn–1). Geometric analysis of the scatterplot allows short-term and long-term heart rate variability (HRV) to be assessed. A three-dimensional construct is also possible, where the third axis represents the density of values, at any given RR vs. RRn–1 intersection. Topological methods of analysis can compute the density distribution function or compactness of a dataset. Scatterplots that otherwise appear very similar in the two-dimensional plot may be clearly differentiated using this approach. Correct characterization may improve the ability of scatterplot analysis to predict outcomes in cardiovascular disease. We have assessed two computational approaches that take account of scatterplot density, namely, the heart rate variability fraction and the compactness measure. Scatterplots were constructed from three double-blind and randomized placebo controlled studies conducted in a total of 49 healthy subjects. Single oral doses of antagonists (atenolol 50 mg [beta-1, propranolol 160 mg [beta-1 and beta-2], and ICI 118,551 25 mg [beta-2]) or agonists (xamoterol 200 mg [beta-1], salbutamol 8 mg [beta-2], prenalterol 50 mg [beta-1 and beta-2], and pindolol 10 mg [mainly beta-2] of the cardiac beta-adrenoceptor were studied. Salbutamol, pindolol, and xamoterol increased compactness and reduced HRV fraction significantly compared with placebo. However, when compared with the more conventional scatterplot parameters, these newer density methods were found to be less discriminating. An alternative approach to improve scatterplot discrimination, using the combination of several scatterplot features, is under investigation.
This record has no associated files available for download.
More information
Published date: 2000
Keywords:
heart rate variability, scatterplot, compactness, beta-adrenoceptor, agonist antagonist
Identifiers
Local EPrints ID: 21462
URI: http://eprints.soton.ac.uk/id/eprint/21462
ISSN: 0920-3206
PURE UUID: f7af8cb7-5eb4-4982-b91a-d4ff501b27e3
Catalogue record
Date deposited: 08 Feb 2007
Last modified: 15 Mar 2024 06:30
Export record
Altmetrics
Contributors
Author:
B. Silke
Author:
G.G. Manratty
Author:
S.M. Veres
Author:
J.G. Riddell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics